Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes
University of Calgary
$100,000.00
Proteolytically derived peptide fragments of E-cadherin mediate epithelial restitution: a new paradigm for mucosal healing in inflammatory bowel diseases
FY 2017-18
Summary
Gastroenterologists assess healing of the intestine, not just symptom relief, as the gold standard for determining the effectiveness of drug treatment of IBD. However, the biological mechanisms that regulate the healing process are complex and poorly understood. A more complete understanding of these mechanisms would allow us to better treat IBD and prevent the relapse of disease, potentially through the identification of new therapies. Repair of damage to the epithelium, the layer of cells that lines the intestine, is a critical component of the healing process. A healthy epithelium acts as an important barrier between the gut bacteria that may contribute to disease and the underlying intestinal immune system that participates in inflammation. We propose to study how proteolytic enzymes, which are present in the tissue during inflammation, may target the proteins that help join epithelial cells together. Based on our preliminary experiments, we hypothesize that enzymatic degradation of one important junctional protein, E-cadherin, results in the production of small peptides that may promote epithelial repair and contribute to healing of the inflamed intestine. We have set three aims to test this hypothesis. In Aim 1, we will use state-of-the-art techniques to identify the E-cadherin peptides that are present in inflamed tissue, as well as the enzymes that produce them. In Aim 2, we will identify the biochemical pathways activated by these peptides in epithelial cells to better understand their role in the repair process. In Aim 3, we will use mouse models of intestinal healing to test these peptides as potential new therapies in IBD.
Department
Program
Project Grant - PA: Nutrition, Metabolism and Diabetes
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
384147
Name
MacNaughton Wallace K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Hematology, Digestive Disease & Kidney
Projecttitle
Proteolytically derived peptide fragments of E-cadherin mediate epithelial restitution: a new paradigm for mucosal healing in inflammatory bowel diseases
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Cell Migration; Colitis; Digestomics; E-Cadherin; Epithelium; Inflammation; Mucosal Healing; Proteomics; Signaling
Abstract
Gastroenterologists assess healing of the intestine, not just symptom relief, as the gold standard for determining the effectiveness of drug treatment of IBD. However, the biological mechanisms that regulate the healing process are complex and poorly understood. A more complete understanding of these mechanisms would allow us to better treat IBD and prevent the relapse of disease, potentially through the identification of new therapies. Repair of damage to the epithelium, the layer of cells that lines the intestine, is a critical component of the healing process. A healthy epithelium acts as an important barrier between the gut bacteria that may contribute to disease and the underlying intestinal immune system that participates in inflammation. We propose to study how proteolytic enzymes, which are present in the tissue during inflammation, may target the proteins that help join epithelial cells together. Based on our preliminary experiments, we hypothesize that enzymatic degradation of one important junctional protein, E-cadherin, results in the production of small peptides that may promote epithelial repair and contribute to healing of the inflamed intestine. We have set three aims to test this hypothesis. In Aim 1, we will use state-of-the-art techniques to identify the E-cadherin peptides that are present in inflamed tissue, as well as the enzymes that produce them. In Aim 2, we will identify the biochemical pathways activated by these peptides in epithelial cells to better understand their role in the repair process. In Aim 3, we will use mouse models of intestinal healing to test these peptides as potential new therapies in IBD.
Competitiondate
201803
Approvedterm2
1 yr 0 mth
Pinamesdelim
MacNaughton, Wallace K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~